Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_917_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
32 Мб
Скачать
Unexpected Findings During Laparoscopic Colectomy forCancer:
25
Techniques andStrategies
EricG.Weiss andGiovannada Silva

Introduction

Laparoscopic colectomy for colon cancer is widely accepted and perhaps the proce­dure of choice for the majority of patients with colon cancer. Despite sophisticated preoperative imaging that typically includes a CT scan of the chest, abdomen, and pelvis, as recommended by the National Comprehensive Cancer Network (NCCN) Guidelines and most surgeons’ practices, unexpected intraoperative ndings are sometimes encountered. This chapter focuses on eight ndings that may be encoun­tered during the performance of laparoscopic surgery for colon cancer and how to manage these unexpected ndings so that patient outcome is optimized.
Identification ofthePrimary Tumor or Lack Thereof
Of primary importance in laparoscopic surgery for colon cancer are identication of the cancerous segment and its removal in an oncologically appropriate manner. Although this seems basic and routine, in the early learning curve of laparoscopic colon cancer management, wrong segments were removed for a variety of reasons. Surgeons often embarked on laparoscopic surgery to remove segments based solely on colonoscopic reports rather than intraoperative conrmation. This leads to the realization that preoperative marking using tattoo techniques was extremely impor­tant owing to the fact that, with the loss of tactile sensation associated with
E. G. Weiss (*) · G. da Silva Department of Colorectal Surgery, Cleveland Clinic Florida, Weston, FL, USA e-mail: weisse@ccf.org; dasilvag@ccf.org
© Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 P. Sylla et al. (eds.), The SAGES Manual of Colorectal Surgery,
https://doi.org/10.1007/978-3-030-24812-3_25
399
400
E. G. Weiss and G. da Silva
laparoscopic surgery, the surgeon is more highly reliant on other methods of identi­fying tumors intraoperatively or preoperatively. Thus the importance of reviewing the preoperative imaging, even when a report does not explicitly state that there is a mass or tumor identied in a segment, cannot be overstated. Subtle ndings, par­ticularly with the surgeon’s familiarity with the colonoscopy report, their own phys­ical examination, and, possibly, their own endoscopy (colonoscopy or exible sigmoidoscopy) depending on the situation, will often allow for conrmation of a tumor location. If a PET/CT has been ordered, unless the tumor is mucinous, the location of the tumor is typically PET-avid and will reappear, thus adding a corrobo­rating study in addition to the colonoscopy. In cases of rectal or rectosigmoid tumors, exible endoscopy is notoriously inaccurate in identifying the specic level of the tumor in relation to the anal verge or dentate line. Thus, in these cases, it behooves all surgeons to perform preoperative rigid proctoscopy or exible sig­moidoscopy in the ofce or endoscopy suite to ensure that the tumor is a colonic rather than a rectal lesion. This is important both to ensure removal of the appropri­ate bowel segment and, in the case of rectal cancer, to consider alternative therapeu­tic options based on local staging such as neoadjuvant chemoradiotherapy, a diverting stoma, chemotherapy, etc. Other scenarios in which preoperative imaging can be useful is obtaining a water-soluble contrast enema study (WSCE) in the case of incomplete colonoscopy due to obstruction or partial obstruction. This will pro­vide information regarding the areas not visualized by colonoscopy as well as a “hard copy, road map” as to the location of the tumor.
At the time of the initial colonoscopy, the endoscopist should consider marking a tumor with tattoos [1]. Although until recently there was no standard method of tattooing for localization of tumors during laparoscopic colectomy, several princi­ples should be adhered to. Tattooing should always be placed distal to the tumor so that removal of the tattoo within the segment ensures removal of the tumor. Tattooing should be placed in multiple quadrants of the bowel wall to facilitate visualization of the tattooing. If only one or two tattoos are placed and they happen to be in the mesenteric surface, they will at times be difcult if not impossible to visualize. Therefore placing tattoos in three or four quadrants should be routinely performed. Reviewing the colonoscopy report is sometimes helpful, but the specics of mark­ing are often omitted, and the reports only conrm that marking/tattooing was per­formed. In these cases, discussion with the endoscopist can be useful. Furthermore, in cases where an endoscopist frequently refers patients, it is helpful to discuss the specics of marking/tattooing in advance, which will often preclude the need for repeat colonoscopy and further marking/tattooing or intraoperative maneuvers to identify the correct segment with its associated tumor (Fig.25.1).
At the onset of a laparoscopic procedure, an initial diagnostic laparoscopy should be performed. This entails a general inspection of the peritoneal cavity, liver, and pelvis to look for identifying characteristics of an underlying colonic tumor such as an obvious mass, adherence of omentum to the colon, puckering of the serosa, serosal involvement by the tumor, and visualization of the tattoo mark­ings. If none of the characteristics of a colonic tumor are present and tattooing is
25 Unexpected Findings During Laparoscopic Colectomy forCancer: Techniques…
Fig. 25.1 Preoperative
tattooing
401
not visualized, one needs to consider why the tattoos are not visualized. Is the surgeon looking in the wrong location? Just because a colonoscopy report states a tumor is in the sigmoid, it does not mean that it could not be in the descending, splenic exure, transverse colon, and at times even more proximal. Flipping the omentum up over the transverse colon should be undertaken as sometimes this maneuver will allow visualization of the tattoos/markings. Lastly, mobilizing the exure(s) will sometimes allow visualization if tattoos are on the mesenteric sur­face or blocked by folded or adhesed areas. Another approach is to place a hand port through the expected extraction site to restore tactile sensation and help to identify the tumor and its associated segment.
If all of the above maneuvers are unsuccessful, intraoperative colonoscopy should be performed. For most laparoscopic colorectal procedures, patients should be initially positioned in lithotomy, allowing access to the anus for such potential needs as intraoperative colonoscopy. If this has not already been done, repositioning will be required. Ideally, intraoperative colonoscopy should be performed using CO
endoscopy equipment [2]. If unavailable, clamping the terminal ileum will
2
prevent insufation of the small bowel with room air, which will limit working space and make completion of the surgery more difcult. Once the tumor is identi­ed, placing a tattoo intraoperatively, placing a suture at the site of the tumor, and marking with endoclips are all viable options to preserve identication of the tumor once the colonoscopy has been completed. With all of the tools available both
402
preoperatively and intraoperatively, a “blind colectomy”– without the ability to identify the correct segment prior to excision– should never be performed.
E. G. Weiss and G. da Silva
Invasion ofOther Organs
Despite preoperative, routine, and high-quality CT scans of the chest, abdomen, and pelvis, more advanced disease does sometimes present intraoperatively. Thus on initial diagnostic laparoscopy, assessment for adherence to or involvement of the tumor to other structures should be undertaken. Structures that a primary colon cancer may be adherent to or invading into would include the abdominal wall, omentum, small bowel, duodenum, stomach, retroperitoneum, bladder, and female reproductive organs including the fallopian tubes, ovaries, uterus, and/or vagina. Other structures may be less frequently involved. Regardless, intraoperative assess­ment as to the resectability of these structures en bloc with the primary tumor needs to be undertaken. In addition, a decision needs to be made as to whether the proce­dure should be continued as a laparoscopic approach or converted to an open proce­dure [3]. Involvement of other specialists, if available, may also be required depending on the expertise of the operating surgeon and the organ(s) involved.
One of “the out of the OR” considerations is the potential lack of informed con­sent for the additional surgery that may be necessary. Speaking to family members may be of some benet; however, from a medicolegal standpoint, unless a family member has healthcare power of attorney on behalf of the patient, consent may not be binding or legal. Regardless, doing what is in the patient’s best interest should take precedence and should guide decisions.
The best decision may sometimes be to abort the procedure. However, this is advisable only if an initial diagnostic laparoscopy has been performed. If the proce­dure has advanced (mobilization, vascular division, etc.) in an effort to recognize any secondary involvement of structures, aborting the procedure is not an option.
If the decision is made to proceed with en bloc resection, the operative team should take a “time-out” to discuss the new operation and the steps required and the need for other teams or services, if required. This will then allow the OR staff, the operative team(s), and potential additional services to be called and prepared.

Synchronous Masses/Tumors

Synchronous tumors or cancers are relatively rare, occurring in less than 1–2% of patients with colon cancer, and are usually intraoperatively identied rather than preoperatively during colonoscopy. Although there is a small “miss rate” on colo­noscopy, more typically a synchronous tumor would be proximal to a partially or obstructing tumor that was not traversed at the time of colonoscopy, thereby leaving a segment(s) of the colon that was not endoscopically evaluated. In cases where a complete colonoscopy cannot be performed, a preoperative WSCE is recommended. Not only does WSCE conrm the location of the primary tumor, it can also assess
25 Unexpected Findings During Laparoscopic Colectomy forCancer: Techniques…
areas that were not endoscopically evaluated. In cases where a second tumor is noted preoperatively, an extended resection or, less commonly, two segmental resections should be performed [4, 5].
If the synchronous tumor is noted intraoperatively, similar options are available to the surgeon and patient. Synchronous tumors should raise the suspicion of hered­itary nonpolyposis colorectal cancer (HNPCC) in the appropriately aged patient. Depending on the location of the rst and second tumors, the options remain as above: extended resection such as an extended right colectomy, subtotal colectomy, or total colectomy with ileorectal anastomosis. Even in cases of total abdominal colectomy with ileorectal anastomosis, functional outcomes are good with an aver­age of 24-hour bowel function of two to four bowel movements per day.
403

Meckel’s Diverticulum

Meckel’s diverticulum occurs in 2% of the population as per the “rule of 2s”: a loca­tion of 2feet from the ileocecal valve and ectopic gastric tissue within the diverticu­lum predisposing to GI bleeding in 2% of cases. Incidentally nding a Meckel’s diverticulum is rarely an indication for surgical excision unless bleeding, perfora­tion, diverticulitis, and obstructions have occurred prior to the incidental identica­tion [6]. However, if a decision is made to excise a Meckel’s diverticulum, it is generally safe and well tolerated.

Peritoneal Carcinomatosis

Patients with peritoneal carcinomatosis (PC) typically have other sites of metasta­sis. However, PC may be the only site in up to 25%, and in 10% it is diagnosed at the time of surgery [7]. The presence of PC implies a poorer prognosis to the patient. Traditionally, management of PC has included a combination of systemic therapy and cytoreductive surgery (CRS) followed by intraoperative hyperthermic intraperi­toneal chemotherapy (HIPEC) with mitomycin-C or oxaliplatin (Fig. 25.2). Recently, a French randomized phase III multicenter trial has questioned the addi­tion of HIPEC in these patients showing no difference in survival and an increased incidence of severe complications when compared to CRS alone [8]. Nevertheless, several studies have shown that CRS/HIPEC confers increased median 5-year sur­vival of approximately 30% after R0/R1 resection, depending on the extent of dis­ease and the completeness of CRS [7, 9].
Up-front knowledge of the presence of PC allows the surgeon to prepare for CRS, which entails removal of all visible disease, omentum/parietal peritoneum followed by HIPEC, which is time-consuming and demands structure with special equipment and drugs. More importantly, advance knowledge provides an opportu­nity for a thorough preoperative discussion with the patient regarding the prognosis, benets, and morbidity related to the procedure. CT scan is still considered the best imaging modality to detect PC.The presence of nodular or plaque-like soft tissue
404
Fig. 25.2 Peritoneal
carcinomatosis. (Courtesy of Patricia Sylla, MD)
E. G. Weiss and G. da Silva
masses and thickening of the mesentery in association with ascites are suggestive of the diagnosis. Unfortunately, CT scan accuracy is approximately 65% with low sensitivity for implants less than 1cm. This results in often missed or underesti­mated PC on preoperative imaging [10].
When the surgeon encounters unexpected PC, the rst step is to evaluate the extent of the disease. The peritoneal cancer index (PCI) is one of the most commonly used tools to evaluate the extent of disease. The PCI scores the lesion size from 0 to 3 (0 no tumor, 1 implants 5mm, 2 >5–50mm, or 3 >50mm) in 13 abdominopelvic regions, for a score range from 0 to 39 (13×3). Patients who are physically t and have limited (PCI<20) and potentially completely resectable and/or ablatable dis­ease with no extra-abdominal metastasis are candidates for the procedure [8]. In these cases, a surgeon experienced with CRS/HIPEC should be called in for evalua­tion and/or the extent of the disease well documented with photos or video. While colectomy has been performed in these scenarios, few studies have suggested worse outcomes with CRS/HIPEC preceded by nondenitive surgical intervention due to violation of the planes and adherence of cancer cells in traumatized tissue [11]. A better option might be to perform biopsies and, at a later date, colectomy with con­comitant CRS/HIPEC.Similarly, if the patient has multiple liver metastasis, CRS should not be attempted. The implants should be biopsied and the primary tumor left in place. If the patient is symptomatic, however, the tumor might be resected and/or a stoma constructed or a gastrostomy tube placed, as indicated. In all situations, the
25 Unexpected Findings During Laparoscopic Colectomy forCancer: Techniques…
case should be discussed in a multidisciplinary team, and the patient is referred for combination treatment with systemic chemotherapy, CRS, and HIPEC.
405

Liver Metastasis

Liver metastasis is present in approximately 25% of patients diagnosed with colorectal cancer. CT scan is the imaging modality of choice for patients undergo­ing colectomy for colon cancer. As with PC, the diagnosis of liver metastasis alters the patient’s treatment and prognosis. High-quality preoperative imaging is crucial as it demonstrates the number, size, and distribution of the metastasis and the vol­ume of the remaining liver, which is important to determine the resectability of the lesions(s) and best treatment approach.
When the surgeon encounters lesions during laparoscopic exploration that are suggestive of metastasis not detected preoperatively, the decision to proceed with colectomy depends on the number/burden of the liver by the lesion(s) and the patient’s symptoms. If the lesions are multiple and occupy a signicant portion of the liver, biopsy of the most assessable lesion might be performed using an energy device and sent for frozen biopsy, if available. If the patient is asymptomatic, the surgeon may forego colectomy, whereas resection should be performed in the pres­ence of symptoms such as obstruction or bleeding. If only few lesions are noted, the surgeon may proceed with colectomy. In all cases, high-quality imaging +/ biopsy should be obtained postoperatively for further treatment planning. In addition, the patient should be referred to chemotherapy and hepatobiliary surgery, and the case should be discussed in a multidisciplinary tumor board.

Ovarian Mass

The differential diagnosis for ovarian mass includes functional cyst, endometrioma, and benign or malignant neoplasm. The incidence of malignant ovarian tumors increases with age. Approximately 5–30% of ovarian tumors originate from other sites and 3–8% are from the colon. Whereas the appearance of a benign cyst lled with clear uid is reassuring, the ndings of a large, irregular, solid, multiloculated, or xed mass are concerning. The approach to ovarian mass includes a diagnostic or staging phase and an operative phase. The diagnostic phase entails washing for cytologic examination and thorough inspection of all pelvic organs, peritoneal sur­faces, the upper abdomen, the diaphragm, and the liver, in order to rule out macro­scopic evidence of malignancy. Surgical treatment of known ovarian tumors may include debulking with removal of all visible disease and a staging procedure with hysterectomy, bilateral salpingo-oophorectomy, omentectomy, peritoneal biopsies, and bilateral pelvic and para-aortic lymphadenectomy [12]. This might be followed
406
E. G. Weiss and G. da Silva
by intraperitoneal or systemic chemotherapy. Metastatic ovarian tumor may be managed with unilateral or bilateral oophorectomy. Careful preoperative evaluation should identify women who have suspicious adnexal masses, and the patient is referred to a gynecologic oncologic surgeon for possible oophorectomy and imme­diate staging by laparoscopy or laparotomy at the time of colon resection.
If an incidental isolated ovarian mass is found during colectomy for colon can­cer, the surgeon may proceed as planned with colectomy, and gynecologic oncology consult should be obtained, if available. If the mass is suspicious and the patient is postmenopausal, after consent is obtained from the next of kin, the specialist may perform oophorectomy with care to avoid rupture and sent for frozen biopsy. If malignancy is conrmed, immediate full staging including peritoneal washings, total abdominal hysterectomy with bilateral salpingo-oophorectomy, omentectomy, peritoneal biopsies, and pelvic and para-aortic lymphadenectomy might be per­formed, or in a second surgery [13]. This staging procedure can be performed by laparotomy or laparoscopy in experienced hands. If frozen biopsy is not available or the patient’s wishes are unknown, the ovary may be sent for permanent pathology and a second surgery performed at a later date by a specialist after discussion with the patient. Tumor markers can be sent intraoperatively or in the postoperative period.
In a premenopausal patient, reproductive and hormonal issues render the sce­nario more complex. A gynecologic oncology surgeon is called in for evaluation and/or the ndings documented and photos taken. Oophorectomy should be per­formed at a later date after proper discussion and counseling relative to the patient’s reproductive wishes and expected hormonal changes. In cases when a benign­looking cyst is incidentally found, management should be postponed and the patient referred to a specialist.

Malrotation

Intestinal malrotation is a rare congenital disorder that results from incomplete rota­tion and xation during fetal development. It is usually diagnosed in the rst month of life and is extremely rare in adults. Presentation may be acute or chronic, with symptoms of obstruction with abdominal pain and vomiting. Although preoperative CT scan is usually obtained in patients undergoing colectomy for colon cancer, the diagnosis of malrotation is often missed. Findings of reversed relation of superior mesenteric artery and superior mesenteric vein with the vein to the right of the artery, a duodenojejunal junction lying on the right without crossing over to the left (corkscrew sign), a whirled appearance of the vasculature entering the volvulus (whirlpool sign), small bowel loops in the right upper abdomen, lack of visualiza­tion of the cecum in the right lower abdomen, and dilatation of small bowel are suggestive of malrotation (Fig.25.3a, b). The best imaging modality is upper gas­trointestinal series, which may show the duodenojejunal exure to the right of the
25 Unexpected Findings During Laparoscopic Colectomy forCancer: Techniques…
407
Fig. 25.3 (a) CT scan
showing superior mesenteric artery dorsal to superior mesenteric vein. (a Source: From Donaire etal. [14]. Copyright © 2013 Michael Donaire etal. Used under the Creative Commons Attribution License 3.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.). (b) Duodenum does not cross the midline
a
b
abdomen. Upon entering the abdominal cavity, the surgeon may encounter the small bowel to the right of the abdomen (Fig.25.4). Lysis of adhesions should be carried on until the bowel is mobilized off the right abdomen. The colon might be difcult to visualize as it may be dislodged to the left. One should not hesitate to convert to open surgery to properly identify the anatomy. Care should be taken with division of the blood supply.
408
Fig. 25.4 Intestinal
malrotation: cecum to the left and sigmoid to the right
E. G. Weiss and G. da Silva

Conclusion

Unexpected intraoperative ndings are minimized by thorough and high-quality preoperative evaluation and imaging. The decision-making process is based on the knowledge of how to proceed when these ndings are known prior to surgery; mor­bidity of additional treatment; natural history of the disease; surgeon’s experience, resources, and skills; availability of the next of kin; the pathologist for frozen biopsy in some cases; and, above all, the patient’s best interest.

References

1. Letarte F, Webb M, Raval M, Karimuddin A, Brown CJ, Phang PT.Tattooing or not? A review
of current practice and outcomes for laparoscopic colonic resection following endoscopy at a tertiary care centre. Can J Surg. 2017;60(6):394–8.
2. Nakajima K, Lee SW, Sonoda T, Milsom JW. Intraoperative carbon dioxide colonoscopy:
a safe insufation alternative for locating colonic lesions during laparoscopic surgery. Surg Endosc. 2005;19(3):321–5.